what are glp-1 agonists receptor for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonist Shortage: Challenges

Strelitz J, Lawlor ER, Wu Y, Estlin A, Nandakumar G, Ahern AL, et al

Hepatology 64(6):20282037 Wachsmuth HR, Weninger SN, Duca FA (2022) Role of the gutbrain axis in energy and glucose metabolism

14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment

The seven drugs that are currently considered GLP-1 receptor agonists include: Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide extended-release (Bydureon) Exenatide (Byetta) Semaglutide injection (Ozempic, Wegovy) Semaglutide tablet (Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) If all of these drugs influence GLP-1 in similar ways, what makes each of them unique

Weekly injectables (semaglutide, dulaglutide) require one injection per week

One framing invites a medical conversation